Times

The Times front page also features the newly-released picture of the Queen and the Duke of Edinburgh on holiday in Scotland together.

The Times leads on claims by western powers that Russia was behind one of the biggest cyberattacks in history last year.

The Times leads on dire warnings of lengthy delays for travellers arriving back in Britain from next month.

The Times is one of a number of Wednesday’s papers highlighting that a senior civil servant worked at private company Greensill Capital while still in Whitehall. But, it says, the government has admitted the move was permitted by Cabinet Office.

The Times goes with David Cameron’s reaction to the launch of an independent inquiry into lobbying and Greensill Capital, reporting the former prime minister will be happy to discuss his role.

The Queen has described the death of her husband as leaving a “huge void” in her life says The Times.Prince Andrew relayed the comments after attending a church service in Windsor on Sunday, adding that the family was “rallying round” to support her.

The Times also reports on the death of Prince Philip, saying he passed away two months before his 100th birthday. The paper recalls the Queen describing him as “my strength and stay” during their golden wedding celebrations in 1997.

The Times leads with a poll saying Britons overwhelmingly trust the Oxford-AstraZeneca coronavirus jab despite concerns about rare blood clots, suggesting the UK’s vaccination programme is still on track.

The Times says a small trial of the Oxford-AstraZeneca vaccine in children has been paused while the UK medicines regulator looks at reports it may be linked to a tiny number of clots in adults.A University of Oxford spokesperson said there were “no safety concerns” with this specific study, but that further information was being awaited from the Medicines and Healthcare products Regulatory Agency (MHRA).

The Times says a small trial of the Oxford-AstraZeneca vaccine in children has been paused while the UK medicines regulator looks at reports it may be linked to a tiny number of clots in adults.A University of Oxford spokesperson said there were “no safety concerns” with this specific study, but that further information was being awaited from the Medicines and Healthcare products Regulatory Agency (MHRA).